The largest database of trusted experimental protocols

Cgs 21680

Manufactured by Selleck Chemicals
Sourced in United States

The CGS 21680 is a laboratory instrument used for the analysis and detection of specific chemical compounds. It is designed to provide accurate and reliable measurements of the target analytes. The core function of the CGS 21680 is to facilitate the identification and quantification of the substances of interest within a sample.

Automatically generated - may contain errors

2 protocols using cgs 21680

1

Fibrin Gel Delivery of A2A Agonist and Antagonist

Check if the same lab product or an alternative is used in the 5 most similar protocols
The preparation of the fibrin glue and the selection of the A2A receptor agonist and antagonist doses were based on the methods reported by several articles [27 (link)–30 (link)]. Briefly, fibrinogen powder (Solarbio, China) was dissolved in physiological saline into a concentration with 10 mg/ml at 37°C. Thrombin powder (Solarbio, China) was dissolved in 40 mmol/l calcium chloride solution, and the concentration was 20 μg/ml. Then, 5 mg CGS 21680 (specific adenosine A2A receptor agonist; Selleck, USA) or ZM 241385 (specific adenosine A2A receptor antagonist; Selleck, USA) was dissolved in 75 μl DMSO and mixed with thrombin solution into a concentration with 16 mg/ml CGS 21680 or ZM 241385 thrombin solution. Afterwards, 125 μl CGS 21680, ZM 241385, or thrombin solution (with DMSO as the solvent accelerating agent) was mixed with 125 μl fibrinogen solution to form a fibrin gel drug delivery system after 1 min of mixing.
+ Open protocol
+ Expand
2

Intracerebral Delivery of Neuromodulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
All drugs were dispensed on the spot. Clozapine‐N‐oxide (CNO) (Tocris, 4936), fluorocitric acid (FC) (Sigma, F9634), DCPCX (MCE, HY‐100937), SCH58261 (Selleck, S8104), and CGS 21680 (Selleck, S2153) were prepared as stock solutions in dimethyl sulfoxide (DMSO) and subsequently diluted to their final concentrations in sterile 0.9% saline. CCPA (Sigma, C7938) was dissolved directly in sterile 0.9% saline and further diluted to the desired concentration. The final concentrations employed were 100 mM for FC and 10 mM for CCPA, DCPCX, SCH58261, and CGS21680. For intraperitoneal (i.p.) injection, rats were administered CNO at 3 mg/kg body weight or the corresponding vehicle. In the case of Ca2+ and GRABAdo imaging, 10 mM CNO was applied to the slices by dissolving it in the perfused artificial cerebrospinal fluid (ACSF). Intracerebral drug delivery was facilitated through previously implanted infusion cannulas. On the day of the experiment, the internal cannulas, extending 0.5 mm beyond the ends of the guide cannulas, were inserted, and drugs (500 nL/side) were infused. The control groups received an equivalent amount of DMSO dissolved in sterile 0.9% saline or an equivalent volume of sterile 0.9% saline.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!